nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—AGTR2—stomach cancer	0.895	1	CbGaD
Tasosartan—AGTR2—hematopoietic system—stomach cancer	0.00931	0.259	CbGeAlD
Tasosartan—AGTR2—endocrine gland—stomach cancer	0.00535	0.149	CbGeAlD
Tasosartan—AGTR2—liver—stomach cancer	0.00482	0.134	CbGeAlD
Tasosartan—AGTR1—blood vessel—stomach cancer	0.00392	0.109	CbGeAlD
Tasosartan—AGTR1—hematopoietic system—stomach cancer	0.00208	0.058	CbGeAlD
Tasosartan—AGTR1—epithelium—stomach cancer	0.00191	0.053	CbGeAlD
Tasosartan—AGTR1—smooth muscle tissue—stomach cancer	0.00184	0.0511	CbGeAlD
Tasosartan—Irbesartan—JUN—stomach cancer	0.00181	0.658	CrCbGaD
Tasosartan—AGTR1—lymphoid tissue—stomach cancer	0.00147	0.0408	CbGeAlD
Tasosartan—AGTR1—endocrine gland—stomach cancer	0.0012	0.0333	CbGeAlD
Tasosartan—AGTR1—liver—stomach cancer	0.00108	0.0301	CbGeAlD
Tasosartan—AGTR1—lymph node—stomach cancer	0.000828	0.023	CbGeAlD
Tasosartan—CYP3A4—hematopoietic system—stomach cancer	0.000766	0.0213	CbGeAlD
Tasosartan—CYP3A4—digestive system—stomach cancer	0.000532	0.0148	CbGeAlD
Tasosartan—CYP3A4—endocrine gland—stomach cancer	0.00044	0.0122	CbGeAlD
Tasosartan—Losartan—ACE—stomach cancer	0.000417	0.152	CrCbGaD
Tasosartan—CYP3A4—liver—stomach cancer	0.000397	0.011	CbGeAlD
Tasosartan—Valsartan—ALB—stomach cancer	0.00035	0.128	CrCbGaD
Tasosartan—Losartan—ALB—stomach cancer	0.000171	0.0623	CrCbGaD
Tasosartan—AGTR2—Signaling Pathways—RGS2—stomach cancer	0.000146	0.0022	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GAST—stomach cancer	0.000146	0.0022	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KISS1R—stomach cancer	0.000146	0.00219	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.000146	0.00218	CbGpPWpGaD
Tasosartan—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.000144	0.00217	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.000141	0.00212	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FGG—stomach cancer	0.000139	0.00208	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—ADRB2—stomach cancer	0.000137	0.00206	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—VEGFA—stomach cancer	0.000135	0.00202	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PPP2R1A—stomach cancer	0.000134	0.00201	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PRKAA1—stomach cancer	0.000134	0.002	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.000133	0.002	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RBP4—stomach cancer	0.000129	0.00194	CbGpPWpGaD
Tasosartan—AGTR2—GPCR ligand binding—CXCL8—stomach cancer	0.000129	0.00194	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—AGTR2—stomach cancer	0.000119	0.00179	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—F2R—stomach cancer	0.000118	0.00177	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HRH4—stomach cancer	0.000116	0.00174	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TNF—stomach cancer	0.000116	0.00173	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—HTR1A—stomach cancer	0.000115	0.00172	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000114	0.00171	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HSPB1—stomach cancer	0.000111	0.00166	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—ANXA1—stomach cancer	0.000111	0.00166	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—F2R—stomach cancer	0.00011	0.00165	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—BMP2—stomach cancer	0.00011	0.00165	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKR1C3—stomach cancer	0.000108	0.00162	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—ADRB1—stomach cancer	0.000107	0.00161	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HTR1A—stomach cancer	0.000107	0.0016	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000106	0.00159	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HRH4—stomach cancer	0.000105	0.00158	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—stomach cancer	0.000105	0.00158	CbGpPWpGaD
Tasosartan—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000105	0.00157	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—KISS1—stomach cancer	0.000103	0.00155	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PRKCB—stomach cancer	0.000103	0.00155	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ANXA1—stomach cancer	0.000103	0.00155	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ADRB1—stomach cancer	9.99e-05	0.0015	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RPS6—stomach cancer	9.54e-05	0.00143	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—stomach cancer	9.39e-05	0.00141	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KISS1—stomach cancer	9.39e-05	0.00141	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PRKCB—stomach cancer	9.39e-05	0.00141	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6ST—stomach cancer	9.35e-05	0.0014	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GAST—stomach cancer	8.89e-05	0.00133	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—RGS2—stomach cancer	8.89e-05	0.00133	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HBEGF—stomach cancer	8.77e-05	0.00132	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—ADRB2—stomach cancer	8.7e-05	0.00131	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GLI3—stomach cancer	8.61e-05	0.00129	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KISS1R—stomach cancer	8.61e-05	0.00129	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	8.6e-05	0.00129	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6R—stomach cancer	8.34e-05	0.00125	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—RHOA—stomach cancer	8.3e-05	0.00125	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—stomach cancer	8.22e-05	0.00123	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RBP1—stomach cancer	8.21e-05	0.00123	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ADRB2—stomach cancer	8.09e-05	0.00121	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—RGS2—stomach cancer	8.07e-05	0.00121	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GAST—stomach cancer	8.07e-05	0.00121	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PPP2R1A—stomach cancer	7.93e-05	0.00119	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	7.72e-05	0.00116	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—RHOA—stomach cancer	7.54e-05	0.00113	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SMAD4—stomach cancer	7.36e-05	0.00111	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCL8—stomach cancer	7.28e-05	0.00109	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FYN—stomach cancer	6.99e-05	0.00105	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AGTR2—stomach cancer	6.74e-05	0.00101	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—WWOX—stomach cancer	6.69e-05	0.001	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—F2R—stomach cancer	6.66e-05	0.001	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCL8—stomach cancer	6.62e-05	0.000993	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FGFR2—stomach cancer	6.56e-05	0.000985	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR1A—stomach cancer	6.49e-05	0.000974	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ANXA1—stomach cancer	6.26e-05	0.00094	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HRH4—stomach cancer	6.22e-05	0.000934	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—WIF1—stomach cancer	6.22e-05	0.000934	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AGTR2—stomach cancer	6.12e-05	0.000918	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADRB1—stomach cancer	6.07e-05	0.000911	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—F2R—stomach cancer	6.05e-05	0.000908	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IRS2—stomach cancer	6.01e-05	0.000902	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR1A—stomach cancer	5.89e-05	0.000884	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CAV1—stomach cancer	5.83e-05	0.000875	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APOA1—stomach cancer	5.81e-05	0.000873	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKAB1—stomach cancer	5.74e-05	0.000862	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	5.72e-05	0.000859	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ANXA1—stomach cancer	5.69e-05	0.000854	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RNF43—stomach cancer	5.55e-05	0.000832	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PRKCB—stomach cancer	5.55e-05	0.000832	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KISS1—stomach cancer	5.55e-05	0.000832	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6ST—stomach cancer	5.52e-05	0.000829	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	5.52e-05	0.000828	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADRB1—stomach cancer	5.51e-05	0.000827	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	5.45e-05	0.000817	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	5.44e-05	0.000817	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APC—stomach cancer	5.31e-05	0.000797	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—PIK3CA—stomach cancer	5.28e-05	0.000793	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	5.14e-05	0.000772	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—MAPK3—stomach cancer	5.08e-05	0.000763	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FST—stomach cancer	4.94e-05	0.000742	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6R—stomach cancer	4.93e-05	0.00074	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADRB2—stomach cancer	4.91e-05	0.000738	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HBEGF—stomach cancer	4.84e-05	0.000726	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—MAPK1—stomach cancer	4.84e-05	0.000726	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—EGFR—stomach cancer	4.84e-05	0.000726	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GAST—stomach cancer	4.77e-05	0.000716	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RGS2—stomach cancer	4.77e-05	0.000716	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	4.73e-05	0.000709	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTT1—stomach cancer	4.62e-05	0.000694	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CA—stomach cancer	4.62e-05	0.000694	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SERPINE1—stomach cancer	4.61e-05	0.000693	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	4.57e-05	0.000686	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—KRAS—stomach cancer	4.57e-05	0.000686	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGG—stomach cancer	4.52e-05	0.000679	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADRB2—stomach cancer	4.46e-05	0.00067	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RHOA—stomach cancer	4.45e-05	0.000668	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOS3—stomach cancer	4.41e-05	0.000661	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	4.38e-05	0.000658	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PPP2R1A—stomach cancer	4.37e-05	0.000657	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	4.37e-05	0.000656	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKAA1—stomach cancer	4.35e-05	0.000653	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RBP4—stomach cancer	4.2e-05	0.000631	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL8—stomach cancer	4.2e-05	0.000631	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CA—stomach cancer	4.2e-05	0.00063	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	4.18e-05	0.000628	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ERBB2—stomach cancer	4.12e-05	0.000619	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL8—stomach cancer	3.91e-05	0.000587	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—HRAS—stomach cancer	3.88e-05	0.000583	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN1B—stomach cancer	3.82e-05	0.000573	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—stomach cancer	3.72e-05	0.000558	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCND1—stomach cancer	3.64e-05	0.000547	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—JUN—stomach cancer	3.63e-05	0.000545	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HSPB1—stomach cancer	3.61e-05	0.000543	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AGTR2—stomach cancer	3.61e-05	0.000543	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—F2R—stomach cancer	3.57e-05	0.000536	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BMP2—stomach cancer	3.57e-05	0.000536	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP9—stomach cancer	3.53e-05	0.000531	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CDKN1A—stomach cancer	3.52e-05	0.000529	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKR1C3—stomach cancer	3.52e-05	0.000528	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR1A—stomach cancer	3.48e-05	0.000522	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK8—stomach cancer	3.44e-05	0.000516	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PRKCB—stomach cancer	3.37e-05	0.000506	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ANXA1—stomach cancer	3.36e-05	0.000504	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRB1—stomach cancer	3.25e-05	0.000488	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTP1—stomach cancer	3.2e-05	0.000481	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—stomach cancer	3.17e-05	0.000476	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	3.16e-05	0.000474	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—STAT3—stomach cancer	3.14e-05	0.000472	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RPS6—stomach cancer	3.11e-05	0.000467	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PRKCB—stomach cancer	3.06e-05	0.000459	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6ST—stomach cancer	3.05e-05	0.000457	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK3—stomach cancer	3e-05	0.000451	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTM1—stomach cancer	2.94e-05	0.000442	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MYC—stomach cancer	2.92e-05	0.000438	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	2.9e-05	0.000436	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HBEGF—stomach cancer	2.86e-05	0.000429	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK1—stomach cancer	2.86e-05	0.000429	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGFR—stomach cancer	2.86e-05	0.000429	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ACAD8—stomach cancer	2.76e-05	0.000414	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6R—stomach cancer	2.72e-05	0.000408	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—RHOA—stomach cancer	2.7e-05	0.000406	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KRAS—stomach cancer	2.7e-05	0.000405	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRB2—stomach cancer	2.64e-05	0.000396	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PPP2R1A—stomach cancer	2.58e-05	0.000388	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CA—stomach cancer	2.48e-05	0.000372	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GMPR2—stomach cancer	2.46e-05	0.000369	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—RHOA—stomach cancer	2.46e-05	0.000369	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SMAD4—stomach cancer	2.4e-05	0.00036	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TP53—stomach cancer	2.4e-05	0.00036	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL8—stomach cancer	2.37e-05	0.000356	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HRAS—stomach cancer	2.29e-05	0.000344	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FYN—stomach cancer	2.28e-05	0.000342	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—IDH3B—stomach cancer	2.25e-05	0.000337	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SUCLG1—stomach cancer	2.25e-05	0.000337	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—stomach cancer	2.2e-05	0.00033	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL8—stomach cancer	2.16e-05	0.000324	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGFR2—stomach cancer	2.14e-05	0.000321	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NDUFS1—stomach cancer	2.09e-05	0.000313	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NDUFV1—stomach cancer	2.09e-05	0.000313	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IRS2—stomach cancer	1.96e-05	0.000294	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CAV1—stomach cancer	1.9e-05	0.000285	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOA1—stomach cancer	1.89e-05	0.000284	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PGLS—stomach cancer	1.86e-05	0.000279	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—BLVRB—stomach cancer	1.86e-05	0.000279	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCB—stomach cancer	1.81e-05	0.000271	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6ST—stomach cancer	1.8e-05	0.00027	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.78e-05	0.000267	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APC—stomach cancer	1.73e-05	0.00026	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MAPK3—stomach cancer	1.66e-05	0.000249	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6R—stomach cancer	1.61e-05	0.000241	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CKB—stomach cancer	1.58e-05	0.000238	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CA1—stomach cancer	1.58e-05	0.000238	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.58e-05	0.000238	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—FBP1—stomach cancer	1.58e-05	0.000238	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MAPK1—stomach cancer	1.58e-05	0.000237	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EGFR—stomach cancer	1.58e-05	0.000237	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CA—stomach cancer	1.51e-05	0.000226	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SERPINE1—stomach cancer	1.5e-05	0.000226	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KRAS—stomach cancer	1.49e-05	0.000223	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLIN2—stomach cancer	1.49e-05	0.000223	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RHOA—stomach cancer	1.45e-05	0.000218	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CA2—stomach cancer	1.45e-05	0.000217	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOS3—stomach cancer	1.44e-05	0.000215	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NT5E—stomach cancer	1.41e-05	0.000212	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PGAM1—stomach cancer	1.41e-05	0.000212	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CA—stomach cancer	1.37e-05	0.000205	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.35e-05	0.000202	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLCE1—stomach cancer	1.35e-05	0.000202	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ERBB2—stomach cancer	1.34e-05	0.000202	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—UMPS—stomach cancer	1.29e-05	0.000194	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL8—stomach cancer	1.27e-05	0.000191	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HRAS—stomach cancer	1.27e-05	0.00019	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN1B—stomach cancer	1.24e-05	0.000187	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—stomach cancer	1.21e-05	0.000182	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PDHA1—stomach cancer	1.2e-05	0.00018	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ECHS1—stomach cancer	1.2e-05	0.00018	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCND1—stomach cancer	1.19e-05	0.000178	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—JUN—stomach cancer	1.18e-05	0.000178	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—stomach cancer	1.15e-05	0.000173	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN1A—stomach cancer	1.15e-05	0.000172	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TYMP—stomach cancer	1.13e-05	0.000169	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—FADS1—stomach cancer	1.13e-05	0.000169	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK8—stomach cancer	1.12e-05	0.000168	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SREBF2—stomach cancer	1.06e-05	0.000158	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—RORA—stomach cancer	1.04e-05	0.000157	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—stomach cancer	1.03e-05	0.000155	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT3—stomach cancer	1.02e-05	0.000154	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK3—stomach cancer	9.78e-06	0.000147	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALDOB—stomach cancer	9.78e-06	0.000147	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MYC—stomach cancer	9.52e-06	0.000143	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK1—stomach cancer	9.31e-06	0.00014	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGFR—stomach cancer	9.31e-06	0.00014	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALOX5—stomach cancer	9.09e-06	0.000136	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DPYD—stomach cancer	8.94e-06	0.000134	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KRAS—stomach cancer	8.79e-06	0.000132	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CA—stomach cancer	8.08e-06	0.000121	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTT1—stomach cancer	7.91e-06	0.000119	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2A6—stomach cancer	7.82e-06	0.000117	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TP53—stomach cancer	7.81e-06	0.000117	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AKR1C3—stomach cancer	7.6e-06	0.000114	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HRAS—stomach cancer	7.47e-06	0.000112	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ENO1—stomach cancer	7.41e-06	0.000111	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—stomach cancer	7.15e-06	0.000107	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CD44—stomach cancer	6.57e-06	9.86e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPP2R1A—stomach cancer	5.59e-06	8.39e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTP1—stomach cancer	5.48e-06	8.23e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HMOX1—stomach cancer	5.4e-06	8.11e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TYMS—stomach cancer	5.1e-06	7.65e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTM1—stomach cancer	5.04e-06	7.56e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ERCC2—stomach cancer	4.74e-06	7.11e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MTHFR—stomach cancer	4.45e-06	6.68e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CAV1—stomach cancer	4.11e-06	6.16e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOA1—stomach cancer	4.1e-06	6.15e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARG—stomach cancer	3.61e-06	5.42e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—stomach cancer	3.25e-06	4.87e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NOS3—stomach cancer	3.1e-06	4.66e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—stomach cancer	2.84e-06	4.26e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.75e-06	2.62e-05	CbGpPWpGaD
